At the hepatic level, the gut-derived pathogen K. pneumoniae surface protein PBP1B interacts with and activates TLR4 on HCC cells, leading to increased cell proliferation and activation of oncogenic signaling, whereas TLR4 inhibition represses K. pneumonia-induced HCC progression [22]. Here, TLR4 is linked to hepatocellular carcinoma.